Anthony M. Joshua

机构：Prostate Cancer Foundation of Australia, The University of Sydney, Garvan Institute of Medical Research, Princess Margaret Cancer Centre, UNSW Sydney, St Vincent's Hospital Melbourne, St Vincent's Hospital Sydney, St Vincent’s Private Hospital Sydney, Prostate Cancer Research, St Vincent's Clinic, The Kinghorn Cancer Centre, Australian and New Zealand Urogenital and Prostate Cancer Trials Group · ORCID：0000-0001-5159-4580

发表论文 802 篇 · 总被引 31699 次 · h-index 71

代表论文

• Data from Clonal Hematopoiesis after <sup>177</sup>Lu-PSMA-617 Radioligand Therapy in Prostate Cancer (2026 · 被引 1)
• Worldwide Innovative Network Consortium: Building a Common Global Cancer Database (2026 · JCO Global Oncology)
• De-escalation Therapy in Metastatic Prostate Cancer: A Retrospective Study on Intermittent ADT and ARPI combination Treatment (2026 · Clinical Genitourinary Cancer)
• Eight-year outcomes of testosterone suppression plus enzalutamide or a non-steroidal anti-androgen for metastatic, hormone-sensitive prostate cancer (ENZAMET; ANZUP 1304) (2026 · Annals of Oncology)
• Network-Integrated Platform for Clinical Trial Navigation from the New South Wales Early Phase Clinical Trials Alliance (2026 · Clinical Cancer Research)
• Supplementary Tables S1 - S6 from Clonal Hematopoiesis after <sup>177</sup>Lu-PSMA-617 Radioligand Therapy in Prostate Cancer (2026)